Related Experiment Video
Updated: Jan 22, 2026
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Published on: October 3, 2025
Budding yeast greatwall and endosulfines control activity and spatial regulation of PP2A(Cdc55) for timely mitotic
Maria Angeles Juanes1, Rita Khoueiry, Thomas Kupka
1Centre de Recherche en Biochimie Macromoléculaire, Montpellier, France.
Abstract:
Entry into mitosis is triggered by cyclinB/Cdk1, whose activity is abruptly raised by a positive feedback loop. The Greatwall kinase phosphorylates proteins of the endosulfine family and allows them to bind and inhibit the main Cdk1-counteracting PP2A-B55 phosphatase, thereby promoting mitotic entry. In contrast to most eukaryotic systems, Cdc14 is the main Cdk1-antagonizing phosphatase in budding yeast, while the PP2A(Cdc55) phosphatase promotes, instead of preventing, mitotic entry by participating to the positive feedback loop of Cdk1 activation. Here we show that budding yeast endosulfines (Igo1 and Igo2) bind to PP2A(Cdc55) in a cell cycle-regulated manner upon Greatwall (Rim15)-dependent phosphorylation. Phosphorylated Igo1 inhibits PP2A(Cdc55) activity in vitro and induces mitotic entry in Xenopus egg extracts, indicating that it bears a conserved PP2A-binding and -inhibitory activity. Surprisingly, deletion of IGO1 and IGO2 in yeast cells leads to a decrease in PP2A phosphatase activity, suggesting that endosulfines act also as positive regulators of PP2A in yeast. Consistently, RIM15 and IGO1/2 promote, like PP2A(Cdc55), timely entry into mitosis under temperature-stress, owing to the accumulation of Tyr-phosphorylated Cdk1. In addition, they contribute to the nuclear export of PP2A(Cdc55), which has recently been proposed to promote mitotic entry. Altogether, our data indicate that Igo proteins participate in the positive feedback loop for Cdk1 activation. We conclude that Greatwall, endosulfines, and PP2A are part of a regulatory module that has been conserved during evolution irrespective of PP2A function in the control of mitosis. However, this conserved module is adapted to account for differences in the regulation of mitotic entry in different organisms.
Insights
Budding yeast endosulfines (Igo1, Igo2) regulate entry into mitosis by interacting with PP2A(Cdc55) phosphatase. This conserved module, involving Greatwall kinase, adapts to different organisms
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Mitotic entry is controlled by cyclinB/Cdk1 activity, regulated by feedback loops.
- Greatwall kinase phosphorylates endosulfines, inhibiting PP2A-B55 phosphatase to promote mitosis.
- Budding yeast utilizes Cdc14 as the main Cdk1 antagonist, with PP2A(Cdc55) promoting mitosis.
Purpose of the Study:
- To investigate the role of budding yeast endosulfines (Igo1, Igo2) in mitotic regulation.
- To determine if yeast endosulfines possess conserved PP2A-binding and inhibitory activities.
- To elucidate the conserved regulatory module of Greatwall, endosulfines, and PP2A in mitosis.
Main Methods:
- Investigated cell cycle-regulated binding of Igo1/Igo2 to PP2A(Cdc55) upon Rim15 phosphorylation.
- Assessed inhibitory activity of phosphorylated Igo1 on PP2A(Cdc55) in vitro and in Xenopus egg extracts.
- Analyzed the effect of IGO1/IGO2 deletion on PP2A activity and mitotic entry under temperature stress.
Main Results:
- Yeast endosulfines (Igo1, Igo2) bind PP2A(Cdc55) in a cell cycle-dependent manner.
- Phosphorylated Igo1 inhibits PP2A(Cdc55) and promotes mitotic entry, showing conserved activity.
- Endosulfines also positively regulate PP2A activity in yeast and contribute to nuclear export of PP2A(Cdc55).
Conclusions:
- Igo proteins are integral to the positive feedback loop activating Cdk1 in budding yeast.
- Greatwall, endosulfines, and PP2A form a conserved regulatory module for mitosis.
- This module is adaptable, accommodating variations in mitotic entry control across species.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Small interfering RNAs (siRNA)
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Hepatic Drug Excretion: Influencing Factors